Related Experiment Video
Updated: Jul 6, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Antiretroviral regimens for treatment-experienced patients with HIV-1 infection
1Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, David Geffen School of Medicine at UCLA, Division of HIV Medicine and Infectious Diseases, 1124 W Carson Street, N-24, Torrance, CA 90502, USA.
Background:
A significant number of treatment-experienced patients with HIV-1 infection develop drug-resistant virus.
Objective:
To define strategies for managing the antiretroviral-experienced patient and summarize current data with commonly used drugs for this population.
Methods:
This review incorporated data from most recent antiretroviral treatment guidelines, published papers on related topics, and peer-reviewed publications or presentations at research meetings on the safety and efficacy of agents commonly used in this patient population.
Results/Conclusion:
The patient experiencing virologic failure on treatment must be evaluated for their ability to adhere with therapy and to define the number of available active drugs. A viable regimen should include at least two fully active agents, with the goal being to achieve complete virologic suppression.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Antiviral Nucleoside Inhibitors
Inhibitors of Virion Maturation and Assembly
Retroviruses
Size and Structure of Viral Genomes
Inhibitors of Viral Protein Synthesis

